Evaluasi Penggunaan Obat Antihipertensi Pada Pasien Diabetes Mellitus Tipe-2 Di Bangsal Rawat Inap RSUD H. Abdul Manap Kota Jambi Tahun 2018
DOI:
https://doi.org/10.33143/jhtm.v5i2.464Keywords:
Diabetes mellitus tipe 2, Drug Related Problems (DRPs), Obat diabetes melitus, Obat antihipertensi, RSUD H. Abdul Manap Kota JambiAbstract
Abstrak
Evaluasi penggunaan obat merupakan proses penjamin mutu dalam penggunaan obat di rumah sakit yang ditujukan untuk memastikan obat yang digunakan secara tepat,aman dan efektif. Untuk mengetahui ketepatan penggunaan obat yang dilihat dari ketepatan pasien, obat dan dosis yang digunakan. Penelitian ini dilakukan di Instalasi rekam medis RSUD H.Abdul Manap Kota Jambi dari bulan Januari-Desember pada tahun 2018 terhadap data rekam medis pasien yang meliputi, no rekam medis, jenis kelamin, usia,obat dan dosis yang digunakan. Dari 46 sampel terdapat ketepatan pasien ,obat dan dosis sebesar 93,47 %. Obat antihipertensi (ARB) sebesar 76,18 %, kombinasi obat antihipertensi golongan (ACEI) sebesar 52 %.
References
World Health Organization. (2016). Diabetes Country Profil Indonesia. Who, 48 (6), 18882A-18882B. https://doi.org/10.1111/j.1467-825X.2011.03931.x
Dian Oktianti, Nurul Fitria Dewi, M. P. (2017). Evaluasi Penggunaan Obat Antihipertensi Pada Pasien Diabetes Mellitus Di Rsi Sultan Agung Semarang 2016. Journal of Clinical Pharmacy. 7, 197–203.
Ida Nurlaelah. (2015). Kajian Interaksi Obat Pada Pengobatan Diabetes Melitus (Dm) Dengan Hipertensi Di Instalasi Rawat Jalan Rsud Undata Periode Maret-Juni Tahun 2014. Galenika Journal of Pharmacy, 1, 35–41
Karlina1, Herman Djewarut2, M. (2018). Faktor-Faktor Yang Berhubungan Dengan Kejadian Hipertensi Pada Lansia Di Wilayah Kerja Puskesmas Kajuara Kecamatan Kajuara Kabupaten Bone, 12, 84–89.
Ririn I. & Friska N. (2017). ini mengapa perempuan lebih rentan hipertensi.healty/women.Suara.com https:www.suara.com/health/2017/02/23/191857/ini-mengapa-perempuan-lebih-rentan-hipertensi. Diakses Agustus 2019.
Olin, B.R., & Pharm, D. (2018). Hypertension: The Silent Killer: Updated JNC-8 Guideline Recommendations. Journal Alabama Pharmacy Association.
Fitrah, A.2017. 'Hubungan Kadar Gula Darah dengan Tekanan Darah Pada Pasien Diabetes Mellitus Tipe 2 Dirumah Sakit Umum Pusat Haji Adam Malik.Program Studi Pendidikan Dokter, Fakultas Kedokteran,Universitas Sumatra Utara.
Lloyd-Jones, D. M. (2017). Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk, (212). Journal Of The American College Of Cardiology https://doi.org/10.1016/j.jacc.2017.07.745
Yosmar, R., Almasdy, D., & Rahma, F. (2018). Survei Risiko Penyakit Diabetes Melitus Terhadap Masyarakat Kota Padang. Survei Risiko Penyakit Diabetes Melitus Terhadap Masyarakat Kota Padang, 5(Agustus 2018), 134–141.
Wells, B. G., Dipiro, J. T., Schwinghammer, T. L., & Dipiro, C. V. (2015). Pharmacotherapy Handbook. Journal of Optoelectronics and Advanced Materials (Vol. 17).
Downloads
Issue
Section
License
I. ORIGINALITY, AUTHORSHIP, AND COPYRIGHT
The manuscripts submitted for publication must be research works written in English that have not been previously published and  are not being considered for publication elsewhere. All the authors must have agreed to the submission and to the order of their names on the title page. They must also have agreed that the corresponding author may act on their behalf throughout the editorial review and publication process. The corresponding author is responsible for obtaining such agreement.
Requests for changes in authorship (order of listing or addition or deletion of names) after submission should be accompanied by signed statements of agreement from all the parties involved. To maintain and protect the publisher‘s ownership and rights and to protect the original authors from misappropriations of their published work, author(s) are required to sign a Journal Publishing Agreement and send it to the editorial office (jhtm@uui.ac.id).
II. PERMISSION
The author is responsible for acquiring the permission(s) to reproduce any copyrighted figures, tables, data, or text that are being used in the submitted paper. Authors should note that text quotations of more than 250 words from a published or copyrighted work will require grant of permission from the original publisher to reprint. The written permission letter(s) must be submitted together with the manuscript.
III. EDITORIAL REVIEW AND REVISION
All papers will be critically read by at least two anonymous reviewers, selected for their competence in the subject area of the paper. Acceptance of the paper will depend upon its scientific merit and suitability for the journal. A paper may be accepted in its original form or subject to revision.
The reviewers' (and editor's) suggestions will be conveyed to the author, who will then have an opportunity to revise the paper. A manuscript returned to an author for revision can be held for a maximum of eight weeks.
The accepted paper will be edited by native English speakers. The cost of language editing service is currently free.
IV. PROOFS
Galley proofs (PDF format) for an accepted article will be sent by e-mail to the corresponding author for copyediting corrections. The core content of an article cannot be changed at this time. It is the author's responsibility to check the entire manuscript, including tables, figure legends, and cited reference numbers, not just the items queried. The proofs should be corrected and mailed to the editorial office within 48 hours of receipt in order to expedite publication. Only one set of corrections will be accepted. In other words, it is important to ensure that all of your corrections are sent to us in one communication.
V. Â REPRINTS
Five free reprint copies of the published article will be shipped to the corresponding authors in Indonesia only, approximately two weeks after the issue is printed. Authors, including overseas authors, who wish to purchase reprints, are required to complete the Reprint Order Form, which will be sent with the galley proofs to corresponding authors. This form must be returned together with the corrected galley proofs.
